Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $18.11M | $10.00k | -$36.35M | -$37.28M | -$0.58 | -86.67% | N/A | N/A | N/A | ||
| INTZ | INTRUSION INC | $8.63M | $5.43M | -$8.78M | -$10.87M | -$8.00 | -22.42% | -13.48% | N/A | N/A | ||
| ASLN | ASLAN PHARMACEUTICALS LTD | $8.12M | $12.00M | N/A | -$35.03M | -$1.75 | N/A | 31.95% | N/A | N/A | ||
| PPBT | PURPLE BIOTECH LTD | $9.96M | $0.00 | $22.27M | $19.88M | N/A | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
| BPTH | BIO-PATH HOLDINGS INC | $3.88M | $0.00 | -$13.78M | -$13.96M | -$26.11 | N/A | N/A | N/A | N/A | ||
| IQ | IQIYI INC | $5.56B | $4.43B | $1.48B | $267.43M | $0.28 | 8.05% | 4.45% | N/A | N/A | ||
| CLNN | CLENE INC | $49.58M | $620.00k | -$41.91M | -$48.81M | -$0.46 | 12.73% | N/A | N/A | N/A | ||
| BNED | BARNES & NOBLE EDUCATION INC | $9.46M | $1.55B | -$10.93M | -$82.10M | -$1.56 | 1.30% | -5.55% | N/A | N/A | 2024-06-05 | |
| BIOL | BIOLASE INC | $5.31M | $48.83M | -$15.50M | -$38.26M | -$20.34 | 0.13% | 1.00% | N/A | N/A | ||
| LIFE | ATYR PHARMA INC | $133.19M | $588.00k | -$51.17M | -$53.93M | -$0.90 | -94.34% | N/A | N/A | N/A | 2024-06-05 | |
| APLM | APOLLOMICS INC | $30.43M | $0.00 | -$171.77M | -$172.60M | -$2.32 | N/A | N/A | N/A | N/A | ||
| LYRA | LYRA THERAPEUTICS INC | $22.44M | $1.68M | -$68.69M | -$68.88M | -$1.20 | 28.74% | N/A | N/A | N/A | 2024-06-13 | |
| GOSS | GOSSAMER BIO INC | $165.14M | $0.00 | -$155.21M | -$172.58M | -$1.00 | N/A | N/A | N/A | N/A | ||
| OCUP | OCUPHIRE PHARMA INC | $44.98M | $19.01M | -$11.28M | -$11.30M | -$0.48 | -54.30% | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $47.74M | $0.00 | -$40.07M | -$40.09M | -$1.59 | N/A | N/A | N/A | N/A | ||
| MVST | MICROVAST HOLDINGS INC | $132.91M | $341.00M | -$69.40M | -$101.58M | -$0.32 | 58.75% | N/A | N/A | N/A | 2024-06-04 | |
| CKPT | CHECKPOINT THERAPEUTICS INC | $65.59M | $68.00k | -$52.32M | -$52.32M | -$2.77 | -61.14% | -54.57% | N/A | N/A | ||
| VIRX | VIRACTA THERAPEUTICS INC | $31.81M | $0.00 | -$43.83M | -$47.99M | -$1.23 | N/A | N/A | N/A | N/A | 2024-06-18 | |
| DARE | DARE BIOSCIENCE INC | $43.98M | $2.82M | -$28.77M | -$28.87M | -$0.32 | -71.83% | N/A | N/A | N/A | ||
| APTO | APTOSE BIOSCIENCES INC | $19.41M | $0.00 | -$46.73M | -$47.17M | -$6.20 | N/A | N/A | N/A | N/A | ||
| SYBX | SYNLOGIC INC | $19.67M | $3.21M | -$68.01M | -$73.22M | -$7.96 | 188.74% | 5.06% | N/A | N/A | 2024-06-14 | |
| FEMY | FEMASYS INC | $28.66M | $1.05M | -$13.45M | -$14.90M | -$0.84 | -11.00% | N/A | N/A | N/A | ||
| IMRX | IMMUNEERING CORP | $45.67M | $0.00 | -$53.41M | -$54.18M | -$1.87 | -100.00% | N/A | N/A | N/A | ||
| GNLX | GENELUX CORP | $97.19M | $8.00k | -$25.42M | -$25.78M | -$0.97 | -99.93% | N/A | N/A | N/A | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $93.21M | $0.00 | -$51.60M | -$55.09M | -$1.25 | -100.00% | N/A | N/A | N/A | 2024-06-13 | |
| LUMO | LUMOS PHARMA INC | $21.35M | $1.53M | -$37.12M | -$37.13M | -$4.59 | -27.48% | -9.94% | N/A | N/A | 2024-05-31 | |
| GOEV | CANOO INC | $196.79M | $886.00k | -$295.04M | -$323.44M | $2.10 | N/A | N/A | -57.40% | N/A | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | $12.32M | $0.00 | -$27.77M | -$29.98M | -$0.69 | N/A | N/A | N/A | N/A | 2024-05-29 | |
| INAB | IN8BIO INC | $45.01M | $0.00 | -$28.50M | -$31.04M | -$0.91 | N/A | N/A | N/A | N/A | ||
| CVKD | CADRENAL THERAPEUTICS INC | $6.88M | $0.00 | -$4.84M | -$4.85M | -$0.31 | N/A | N/A | N/A | N/A | ||
| MRNS | MARINUS PHARMACEUTICALS INC | $71.41M | $28.29M | -$129.08M | -$145.34M | -$2.64 | 30.53% | N/A | N/A | N/A | 2024-05-22 | |
| GEVO | GEVO INC | $166.54M | $17.13M | -$46.43M | -$67.47M | -$0.29 | 242.39% | -11.20% | N/A | N/A | 2024-05-21 | |
| PRST | PRESTO AUTOMATION INC | $13.17M | $21.20M | -$48.24M | -$66.42M | -$1.31 | -30.61% | N/A | N/A | N/A | ||
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.76M | $92.73k | -$8.35M | -$8.43M | -$2.31 | -53.29% | -68.21% | N/A | N/A | ||
| TPST | TEMPEST THERAPEUTICS INC | $71.54M | $0.00 | -$26.24M | -$29.76M | -$1.72 | N/A | N/A | N/A | N/A | 2024-06-13 | |
| CARA | CARA THERAPEUTICS INC | $44.01M | $16.94M | -$117.75M | -$122.54M | -$2.26 | -60.83% | -1.04% | N/A | N/A | ||
| AMPX | AMPRIUS TECHNOLOGIES INC | $122.81M | $10.71M | -$32.92M | -$37.56M | -$0.43 | 259.64% | N/A | N/A | N/A | ||
| EOSE | EOS ENERGY ENTERPRISES INC | $146.94M | $14.14M | -$148.45M | -$204.61M | -$1.40 | -39.71% | N/A | N/A | N/A | 2024-06-12 | |
| DDC | DDC ENTERPRISE LTD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| OTLK | OUTLOOK THERAPEUTICS INC | $171.56M | $0.00 | -$156.86M | -$159.13M | -$11.41 | N/A | -100.00% | N/A | N/A | ||
| ACET | ADICET BIO INC | $129.01M | $0.00 | -$130.23M | -$139.79M | -$2.94 | N/A | -100.00% | N/A | N/A | 2024-06-05 | |
| FBIO | FORTRESS BIOTECH INC | $35.05M | $85.11M | -$31.95M | -$62.86M | -$6.10 | 32.48% | 25.39% | N/A | N/A | 2024-05-23 | |
| TARA | PROTARA THERAPEUTICS INC | $77.01M | $0.00 | -$42.12M | -$42.47M | -$3.74 | N/A | N/A | N/A | N/A | ||
| SPRB | SPRUCE BIOSCIENCES INC | $31.69M | $10.13M | -$47.11M | -$46.75M | -$1.13 | 415.63% | N/A | N/A | N/A | 2024-05-22 | |
| MBRX | MOLECULIN BIOTECH INC | $11.63M | $0.00 | -$26.70M | -$26.82M | -$13.04 | N/A | N/A | N/A | N/A | 2024-06-14 | |
| VOR | VOR BIOPHARMA INC | $122.87M | $0.00 | -$112.63M | -$120.23M | -$1.77 | N/A | N/A | N/A | N/A | 2024-05-23 | |
| CMPS | COMPASS PATHWAYS PLC | $546.36M | $0.00 | -$122.97M | -$129.44M | -$2.35 | N/A | N/A | N/A | N/A | ||
| AQMS | AQUA METALS INC | $49.48M | $25.00k | -$23.12M | -$25.08M | -$0.24 | 525.00% | -62.01% | N/A | N/A | ||
| IKNA | IKENA ONCOLOGY INC | $67.56M | $3.85M | -$67.40M | -$70.09M | -$1.57 | -78.07% | N/A | N/A | N/A | 2024-06-07 | |
| NTBL | NOTABLE LABS LTD | $9.38M | $311.00k | -$11.19M | -$12.22M | -$5.05 | N/A | -13.47% | N/A | N/A | ||
| SGMT | SAGIMET BIOSCIENCES INC | $151.59M | $2.00M | -$27.78M | -$27.92M | -$38.69 | N/A | N/A | N/A | N/A | ||
| AGEN | AGENUS INC | $220.49M | $161.42M | -$114.19M | -$239.61M | -$12.64 | 69.94% | 7.01% | N/A | N/A | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $12.37M | $0.00 | N/A | -$19.34M | -$1.56 | N/A | N/A | N/A | N/A | ||
| PGEN | PRECIGEN INC | $353.39M | $5.44M | -$90.64M | -$96.91M | -$0.39 | -76.60% | -47.32% | N/A | N/A | ||
| SBEV | SPLASH BEVERAGE GROUP INC | $13.30M | $14.57M | -$19.17M | -$21.95M | -$0.49 | -27.10% | N/A | N/A | N/A | 2024-06-04 | |
| IPA | IMMUNOPRECISE ANTIBODIES LTD | $29.47M | $17.41M | -$7.05M | -$10.48M | -$0.41 | 16.75% | N/A | N/A | N/A | 2024-07-05 | |
| HOOK | HOOKIPA PHARMA INC | $80.25M | $53.55M | -$43.89M | -$47.52M | -$0.50 | 235.12% | 40.26% | N/A | N/A | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $200.13M | $8.00M | -$22.96M | -$23.66M | -$0.13 | -32.48% | 8.94% | N/A | N/A | ||
| IVA | INVENTIVA SA | $190.33M | $25.18M | -$109.06M | -$120.03M | -$2.64 | 28.59% | 24.86% | N/A | N/A | 2024-05-29 | |
| CDTX | CIDARA THERAPEUTICS INC | $54.74M | $46.38M | -$35.16M | -$36.47M | -$8.08 | -44.42% | N/A | N/A | N/A | 2024-06-21 | |
| GRTS | GRITSTONE BIO INC | $81.10M | $15.65M | -$117.74M | -$144.89M | -$1.24 | 2.95% | 43.92% | N/A | N/A | ||
| CLRB | CELLECTAR BIOSCIENCES INC | $119.38M | $0.00 | -$50.75M | -$50.98M | -$3.08 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.